112 web-programmer-developer-"https:"-"https:"-"https:"-"https:"-"https:" positions at City of Hope
Sort by
Refine Your Search
-
within the translational hematopathology program led by Dr. M. James You. The successful candidate will develop a focused research program aligned with the laboratory's core themes, including leukemic stem
-
About the lab We are a newly established computational research group at the Translational Genomics Research Institute developing and applying pangenome methods to study genome variation and
-
Querfeld, M.D., Ph.D., director of the Cutaneous Lymphoma program, seeks better treatment options for cutaneous T cell lymphoma (CTCL), a rare form of lymphoma that first appears on the skin but can also
-
development, stem cell (including iPSCs) research, depending on the individual’s interests and strengths. Under general supervision of the Principal Investigator, or designee, the RA II directs the animal work
-
that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and
-
collaboration with Principal Investigators and the Disease/Modality-specific Study Teams, will have primary responsibility for the clinical research content development and maintenance of all therapeutic and
-
collaboration with related departments – including Protocol Content Administrators responsible for Epic Beacon Treatment Plan development, and Clinical Research Billing. The role will also maintain responsibility
-
comprehensive cancer center that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development
-
genes related to the development of type 2 diabetes and cardiovascular disease in the Hispanic population. He also continues to oversee the Diabetes and Cardiovascular Risk Reduction Program, which he
-
opportunity: · Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection, prognosis, and predictive responses to chemotherapies and